Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Cancer|March 10, 2000
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinomaM Lein, K Jung, C Laube, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosisI Sturm, H Petrowsky, R Volz, et al.Bone Marrow Transplantation|April 25, 2001
Cardiac death after autologous stem cell transplantation (ASCT) for treatment of systemic sclerosis (SSc): no evidence for cyclophosphamide-induced cardiomyopathyO Rosen, G Massenkeil, F Hiepe, et al.Shock (Augusta, Ga.)|April 1, 1997
Induction of heat shock protein 70 by zinc-bis-(DL-hydrogenaspartate) reduces cytokine liberation, apoptosis, and mortality rate in a rat model of LD100 endotoxemiaB Klosterhalfen, S Hauptmann, F A Offner, et al.International Journal of Cancer|July 31, 2001
Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?K Jung, C Stephan, U Elgeti, et al.Oncogene|September 6, 2006
Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcomaH Taubert, T Greither, D Kaushal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2005
Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trialP Schmid, J Krocker, C Jehn, et al.Oncogene|May 26, 2007
Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patientsH Taubert, P Würl, T Greither, et al.British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.Pageof 10